Although the anti-PCSK9 vaccine could protect the vaccinated rats against STZ-induced hyperglycemia and improved glucose hemostasis to the same extent as the control rats, the loss of body weight gain in the VS group was evident in a similar fashion to the DC group. Here, PCSK9 is linked to Hyperglycemia.